p21-Activated kinase inhibitors: a patent review

By Crawford James J   Hoeflich Klaus P   Rudolph Joachim  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 293-310

Informa Healthcare

Access to resources Recommend Favorite

AMP-Activated Protein Kinase Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells

By Jia Fang   Wu Chunfang   Chen Zhenyue   Lu Guoping  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 21-29

Springer Publishing Company

Access to resources Recommend Favorite

Immunosuppressant rapamycin inhibits protein kinase C and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis

By Oh C.-D.   Kim S.-J.   Ju J.-W.   Song W.K.   Kim J.-H.   Yoo Y.J.   Chun J.-S.  

European Journal of Pharmacology, Vol. 427, Iss. 3, 2001-09 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite

The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction

By  

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 660-666

Bentham Science Publishers

Access to resources Recommend Favorite

Naloxone Inhibition of Lipopolysaccharide-induced Activation of Retinal Microglia is Partly Mediated via the p38 Mitogen Activated Protein Kinase Signalling Pathway

By Xu YF   Fu Ll   Jiang CH   Qin YW   Ni YQ   Fan JW  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1438-1448

Field House Publishing

Access to resources Recommend Favorite